微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 31.15% | -21.57% | -16.55% | 103/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 37.33% | -3.97% | -4.97% | 95/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 39.28% | 0.4% | 0.27% | 94/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 39.18% | 9.18% | -1.37% | 97/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 39.72% | 24.99% | 2.18% | 89/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 38.88% | -4.68% | -0.64% | 98/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 39.13% | -6.77% | 9.04% | 92/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 35.88% | -17.41% | 12.91% | 98/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 31.78% | -26.72% | -22.08% | 103/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 40.79% | -7.01% | -2.82% | 93/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 41.97% | -7.36% | -3.4% | 86/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 43.45% | -7.05% | 0.18% | 85/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 43.37% | 2% | -1.12% | 79/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 43.86% | -8.52% | -3.18% | 95/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 45.3% | 2% | -3.08% | 81/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 46.74% | -2.17% | -2.52% | 84/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 47.95% | 19.01% | 0.36% | 90/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 47.78% | 2% | 18.59% | 83/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 40.29% | 15.65% | 15.65% | 89/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 34.84% | -0.62% | -0.62% | 90/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 35.05% | 2% | 2% | 80/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |